Base Year
Historical Year
Forecast Year
The global radiodermatitis market is projected to grow at a CAGR of 3.7% between 2024 and 2032, to attain USD 708.84 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of the market for radiodermatitis is largely driven by the rise in cancer incidence and the increase in the worldwide use of radiotherapy for recovery. In addition, a surge in the geriatric population is also fueling the demand for radiodermatitis. Further, the increased demand for the elimination of radiation therapy-related side effects is projected to deliver attractive business growth opportunities for radiodermatitis industry over the forecast period. In the projected timeframe, North America is predicted to be a significant market for radiodermatitis across the globe due to the increasing prevalence of cancer in the US. Growing demand for radiation therapy is also anticipated to be a significant driving force for the North America industry. In Asia-Pacific, rising public and private investment in cancer treatment and healthcare infrastructure is projected to raise the global market for radiodermatitis during the forecast timeframe.
Radiodermatitis is a cutaneous reaction that, during cancer treatment or often after interventional radiology, occurs as one of the side effects of radiotherapy. It is one of the most frequent side effects of radiation therapy for breast, head and neck cancers, lungs, and soft tissue sarcomas used in carcinoma.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
Topical is divided on the basis of type into corticosteroids, hydrophilic creams, antibiotics, among others. Oral segment is bifurcated, based on type, into corticosteroids and oral analgesics and antibiotics. Dressings is divided on the basis of type into hydrogel and hydrocolloid dressing, no sting barrier film, honey impregnated gauze, and silicone coated, among others.
Based on distribution channel, the market is segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increase in cancer cases worldwide is expected to prime the radiodermatitis industry for a stable growth trajectory. There are debilitating side effects of radiation therapy, and radiodermatitis is arguably the worse of the lot. According to the National Institute of Health, it is believed to occur in 85% of cancer patients who are treated with radiation. There is a steadily rising demand from cancer patients for successful palliative care solutions in order to offset the extreme effects of radiation. One of the high impact rendering factors for this sector is the growing number of public and private healthcare organisations actively working to promote awareness about radiodermatitis management and treatment. In addition, these organisations issue guidance and recommendations to treat the disease efficiently, which are expected to broaden the growth potential for the industry over the forecast period. The growing number of clinical trials performed to assess the efficacy of a wide variety of treatment products for radiodermatitis treatment is expected to expand the product pipeline of the market.
The report gives a detailed analysis of the following key players in the global radiodermatitis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is projected to grow at a CAGR of 3.7% between 2024 and 2032.
The industry is being driven by the factors such as the increasing senior population, growing usage of radiotherapy for recovery,rising demand for the eradication of radiation therapy-related side effects, growing number of clinical trials, and rising public and private investment.
The rise in cancer incidences and the expanding number of public and private healthcare organisations actively striving to improve awareness about radiodermatitis management and treatment are the key industry trends propelling the industry forward.
The major regions in the industry are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
The products include topical, oral, and dressings.
Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacies, among others.
The major players in the industry are BMG Pharma S.p.A. and Stratpharma AG, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share